BrainStorm gets FDA okay for stem cell trial in MS patients ..The global MS drugs market is expected to exceed $27 billion by 2025 from $16 billion in 2016, according to Research and Markets.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.